Ki8751_COA_16472_MedChemExpress

合集下载

分子生物学词汇(中英文对照表 )

Gelucire-14-44-SDS-MedChemExpress

Inhibitors, Agonists, Screening LibrariesSafety Data Sheet Revision Date:Nov.-23-2018Print Date:Nov.-23-20181. PRODUCT AND COMPANY IDENTIFICATION1.1 Product identifierProduct name :Gelucire 14/44Catalog No. :HY-Y1892CAS No. :121548-04-71.2 Relevant identified uses of the substance or mixture and uses advised againstIdentified uses :Laboratory chemicals, manufacture of substances.1.3 Details of the supplier of the safety data sheetCompany:MedChemExpress USATel:609-228-6898Fax:609-228-5909E-mail:sales@1.4 Emergency telephone numberEmergency Phone #:609-228-68982. HAZARDS IDENTIFICATION2.1 Classification of the substance or mixtureNot a hazardous substance or mixture.2.2 GHS Label elements, including precautionary statementsNot a hazardous substance or mixture.2.3 Other hazardsNone.3. COMPOSITION/INFORMATION ON INGREDIENTS3.1 SubstancesSynonyms:NoneFormula:N/AMolecular Weight:N/ACAS No. :121548-04-74. FIRST AID MEASURES4.1 Description of first aid measuresEye contactRemove any contact lenses, locate eye-wash station, and flush eyes immediately with large amounts of water. Separate eyelids with fingers to ensure adequate flushing. Promptly call a physician.Skin contactRinse skin thoroughly with large amounts of water. Remove contaminated clothing and shoes and call a physician.InhalationImmediately relocate self or casualty to fresh air. If breathing is difficult, give cardiopulmonary resuscitation (CPR). Avoid mouth-to-mouth resuscitation.IngestionWash out mouth with water; Do NOT induce vomiting; call a physician.4.2 Most important symptoms and effects, both acute and delayedThe most important known symptoms and effects are described in the labelling (see section 2.2).4.3 Indication of any immediate medical attention and special treatment neededTreat symptomatically.5. FIRE FIGHTING MEASURES5.1 Extinguishing mediaSuitable extinguishing mediaUse water spray, dry chemical, foam, and carbon dioxide fire extinguisher.5.2 Special hazards arising from the substance or mixtureDuring combustion, may emit irritant fumes.5.3 Advice for firefightersWear self-contained breathing apparatus and protective clothing.6. ACCIDENTAL RELEASE MEASURES6.1 Personal precautions, protective equipment and emergency proceduresUse full personal protective equipment. Avoid breathing vapors, mist, dust or gas. Ensure adequate ventilation. Evacuate personnel to safe areas.Refer to protective measures listed in sections 8.6.2 Environmental precautionsTry to prevent further leakage or spillage. Keep the product away from drains or water courses.6.3 Methods and materials for containment and cleaning upAbsorb solutions with finely-powdered liquid-binding material (diatomite, universal binders); Decontaminate surfaces and equipment by scrubbing with alcohol; Dispose of contaminated material according to Section 13.7. HANDLING AND STORAGE7.1 Precautions for safe handlingAvoid inhalation, contact with eyes and skin. Avoid dust and aerosol formation. Use only in areas with appropriate exhaust ventilation.7.2 Conditions for safe storage, including any incompatibilitiesKeep container tightly sealed in cool, well-ventilated area. Keep away from direct sunlight and sources of ignition.Recommended storage temperature:Pure form-20°C 3 years4°C 2 yearsIn solvent-80°C 6 months-20°C 1 monthShipping at room temperature if less than 2 weeks.7.3 Specific end use(s)No data available.8. EXPOSURE CONTROLS/PERSONAL PROTECTION8.1 Control parametersComponents with workplace control parametersThis product contains no substances with occupational exposure limit values.8.2 Exposure controlsEngineering controlsEnsure adequate ventilation. Provide accessible safety shower and eye wash station.Personal protective equipmentEye protection Safety goggles with side-shields.Hand protection Protective gloves.Skin and body protection Impervious clothing.Respiratory protection Suitable respirator.Environmental exposure controls Keep the product away from drains, water courses or the soil. Cleanspillages in a safe way as soon as possible.9. PHYSICAL AND CHEMICAL PROPERTIES9.1 Information on basic physical and chemical propertiesAppearance White to off-white (Oil)Odor No data availableOdor threshold No data availablepH No data availableMelting/freezing point No data availableBoiling point/range No data availableFlash point No data availableEvaporation rate No data availableFlammability (solid, gas)No data availableUpper/lower flammability or explosive limits No data availableVapor pressure No data availableVapor density No data availableRelative density No data availableWater Solubility No data availablePartition coefficient No data availableAuto-ignition temperature No data availableDecomposition temperature No data availableViscosity No data availableExplosive properties No data availableOxidizing properties No data available9.2 Other safety informationNo data available.10. STABILITY AND REACTIVITY10.1 ReactivityNo data available.10.2 Chemical stabilityStable under recommended storage conditions.10.3 Possibility of hazardous reactionsNo data available.10.4 Conditions to avoidNo data available.10.5 Incompatible materialsStrong acids/alkalis, strong oxidising/reducing agents.10.6 Hazardous decomposition productsUnder fire conditions, may decompose and emit toxic fumes.Other decomposition products - no data available.11.TOXICOLOGICAL INFORMATION11.1 Information on toxicological effectsAcute toxicityClassified based on available data. For more details, see section 2Skin corrosion/irritationClassified based on available data. For more details, see section 2Serious eye damage/irritationClassified based on available data. For more details, see section 2Respiratory or skin sensitizationClassified based on available data. For more details, see section 2Germ cell mutagenicityClassified based on available data. For more details, see section 2CarcinogenicityIARC: No component of this product present at a level equal to or greater than 0.1% is identified as probable, possible or confirmed human carcinogen by IARC.ACGIH: No component of this product present at a level equal to or greater than 0.1% is identified as a potential or confirmed carcinogen by ACGIH.NTP: No component of this product present at a level equal to or greater than 0.1% is identified as a anticipated or confirmed carcinogen by NTP.OSHA: No component of this product present at a level equal to or greater than 0.1% is identified as a potential or confirmed carcinogen by OSHA.Reproductive toxicityClassified based on available data. For more details, see section 2Specific target organ toxicity - single exposureClassified based on available data. For more details, see section 2Specific target organ toxicity - repeated exposureClassified based on available data. For more details, see section 2Aspiration hazardClassified based on available data. For more details, see section 212. ECOLOGICAL INFORMATION12.1 ToxicityNo data available.12.2 Persistence and degradabilityNo data available.12.3 Bioaccumlative potentialNo data available.12.4 Mobility in soilNo data available.12.5 Results of PBT and vPvB assessmentPBT/vPvB assessment unavailable as chemical safety assessment not required or not conducted.12.6 Other adverse effectsNo data available.13. DISPOSAL CONSIDERATIONS13.1 Waste treatment methodsProductDispose substance in accordance with prevailing country, federal, state and local regulations.Contaminated packagingConduct recycling or disposal in accordance with prevailing country, federal, state and local regulations.14. TRANSPORT INFORMATIONDOT (US)This substance is considered to be non-hazardous for transport.IMDGThis substance is considered to be non-hazardous for transport.IATAThis substance is considered to be non-hazardous for transport.15. REGULATORY INFORMATIONSARA 302 Components:No chemicals in this material are subject to the reporting requirements of SARA Title III, Section 302.SARA 313 Components:This material does not contain any chemical components with known CAS numbers that exceed the threshold (De Minimis) reporting levels established by SARA Title III, Section 313.SARA 311/312 Hazards:No SARA Hazards.Massachusetts Right To Know Components:No components are subject to the Massachusetts Right to Know Act.Pennsylvania Right To Know Components:No components are subject to the Pennsylvania Right to Know Act.New Jersey Right To Know Components:No components are subject to the New Jersey Right to Know Act.California Prop. 65 Components:This product does not contain any chemicals known to State of California to cause cancer, birth defects, or anyother reproductive harm.16. OTHER INFORMATIONCopyright 2018 MedChemExpress. The above information is correct to the best of our present knowledge but does not purport to be all inclusive and should be used only as a guide. The product is for research use only and for experienced personnel. It must only be handled by suitably qualified experienced scientists in appropriately equipped and authorized facilities. The burden of safe use of this material rests entirely with the user. MedChemExpress disclaims all liability for any damage resulting from handling or from contact with this product.Caution: Product has not been fully validated for medical applications. For research use only.Tel: 609-228-6898 Fax: 609-228-5909 E-mail: tech@Address: 1 Deer Park Dr, Suite Q, Monmouth Junction, NJ 08852, USA。

CAS号413611-93-5_10074-G5_MedBio_物理性质

CAS
1、产品物理参数：
常用名
10074-G5
英文名
10074-G5
CAS号
413611-93-5
分子量
332.313
密度
1.4±0.1 g/cm3
沸点
538.6±60.0 °C at 760 mmHg
分子式
C18H12N4O3
熔点
无资料
闪点
279.5±32.9 °C
2、技术资料：
体外研究
10074-G5抑制Daudi Burkitt淋巴瘤细胞的生长并破坏c-Myc / Max二聚化。针对Daudi和HL-60细胞的IC50值分别为15.6和13.5μM[1]。10074-G5在区域Arg363-Ile381中结合Myc肽Myc353-437，Kd值为2.8μM。10074-G5结合在由诱导螺旋结构域（Leu370-Arg378）的N末端的扭结（Asp379-Ile381）产生的空腔中[3]。
≥98%
品牌
货号
中文名称
英文名称
CAS
包装
纯度
MedBio
MED11457
CDK inhibitor II
CDK inhibitor II
1269815-17-9
50mg
≥98%
品牌
货号
中文名称
英文名称
CAS
包装
纯度
MedBio
MED11591
(S)-CCG-1423
(S)-CCG-1423
None
体内研究
静脉注射20 mg / kg小鼠的血浆半衰期为10074-G5，为37分钟，血药浓度峰值为58μM，比肿瘤峰值浓度高10倍[1]。
3、同类产品列表：

TAK-875_SDS_MedChemExpress

Inhibitors, Agonists, Screening LibrariesSafety Data Sheet Revision Date:Jun.-08-2017Print Date:Jun.-08-20171. PRODUCT AND COMPANY IDENTIFICATION1.1 Product identifierProduct name :TAK-875Catalog No. :HY-10480CAS No. :1000413-72-81.2 Relevant identified uses of the substance or mixture and uses advised againstIdentified uses :Laboratory chemicals, manufacture of substances.1.3 Details of the supplier of the safety data sheetCompany:MedChemExpress USATel:609-228-6898Fax:609-228-5909E-mail:sales@1.4 Emergency telephone numberEmergency Phone #:609-228-68982. HAZARDS IDENTIFICATION2.1 Classification of the substance or mixtureNot a hazardous substance or mixture.2.2 GHS Label elements, including precautionary statementsNot a hazardous substance or mixture.2.3 Other hazardsNone.3. COMPOSITION/INFORMATION ON INGREDIENTS3.1 SubstancesSynonyms:Fasiglifam; TAK 875; TAK875Formula:C29H32O7SMolecular Weight:524.63CAS No. :1000413-72-84. FIRST AID MEASURES4.1 Description of first aid measuresEye contactRemove any contact lenses, locate eye-wash station, and flush eyes immediately with large amounts of water. Separate eyelids with fingers to ensure adequate flushing. Promptly call a physician.Skin contactRinse skin thoroughly with large amounts of water. Remove contaminated clothing and shoes and call a physician.InhalationImmediately relocate self or casualty to fresh air. If breathing is difficult, give cardiopulmonary resuscitation (CPR). Avoid mouth-to-mouth resuscitation.IngestionWash out mouth with water; Do NOT induce vomiting; call a physician.4.2 Most important symptoms and effects, both acute and delayedThe most important known symptoms and effects are described in the labelling (see section 2.2).4.3 Indication of any immediate medical attention and special treatment neededTreat symptomatically.5. FIRE FIGHTING MEASURES5.1 Extinguishing mediaSuitable extinguishing mediaUse water spray, dry chemical, foam, and carbon dioxide fire extinguisher.5.2 Special hazards arising from the substance or mixtureDuring combustion, may emit irritant fumes.5.3 Advice for firefightersWear self-contained breathing apparatus and protective clothing.6. ACCIDENTAL RELEASE MEASURES6.1 Personal precautions, protective equipment and emergency proceduresUse full personal protective equipment. Avoid breathing vapors, mist, dust or gas. Ensure adequate ventilation. Evacuate personnel to safe areas.Refer to protective measures listed in sections 8.6.2 Environmental precautionsTry to prevent further leakage or spillage. Keep the product away from drains or water courses.6.3 Methods and materials for containment and cleaning upAbsorb solutions with finely-powdered liquid-binding material (diatomite, universal binders); Decontaminate surfaces and equipment by scrubbing with alcohol; Dispose of contaminated material according to Section 13.7. HANDLING AND STORAGE7.1 Precautions for safe handlingAvoid inhalation, contact with eyes and skin. Avoid dust and aerosol formation. Use only in areas with appropriate exhaust ventilation.7.2 Conditions for safe storage, including any incompatibilitiesKeep container tightly sealed in cool, well-ventilated area. Keep away from direct sunlight and sources of ignition.Recommended storage temperature:Powder-20°C 3 years4°C 2 yearsIn solvent-80°C 6 months-20°C 1 monthShipping at room temperature if less than 2 weeks.7.3 Specific end use(s)No data available.8. EXPOSURE CONTROLS/PERSONAL PROTECTION8.1 Control parametersComponents with workplace control parametersThis product contains no substances with occupational exposure limit values.8.2 Exposure controlsEngineering controlsEnsure adequate ventilation. Provide accessible safety shower and eye wash station.Personal protective equipmentEye protection Safety goggles with side-shields.Hand protection Protective gloves.Skin and body protection Impervious clothing.Respiratory protection Suitable respirator.Environmental exposure controls Keep the product away from drains, water courses or the soil. Cleanspillages in a safe way as soon as possible.9. PHYSICAL AND CHEMICAL PROPERTIES9.1 Information on basic physical and chemical propertiesAppearance White to off-white (Solid)Odor No data availableOdor threshold No data availablepH No data availableMelting/freezing point No data availableBoiling point/range No data availableFlash point No data availableEvaporation rate No data availableFlammability (solid, gas)No data availableUpper/lower flammability or explosive limits No data availableVapor pressure No data availableVapor density No data availableRelative density No data availableWater Solubility No data availablePartition coefficient No data availableAuto-ignition temperature No data availableDecomposition temperature No data availableViscosity No data availableExplosive properties No data availableOxidizing properties No data available9.2 Other safety informationNo data available.10. STABILITY AND REACTIVITY10.1 ReactivityNo data available.10.2 Chemical stabilityStable under recommended storage conditions.10.3 Possibility of hazardous reactionsNo data available.10.4 Conditions to avoidNo data available.10.5 Incompatible materialsStrong acids/alkalis, strong oxidising/reducing agents.10.6 Hazardous decomposition productsUnder fire conditions, may decompose and emit toxic fumes.Other decomposition products - no data available.11.TOXICOLOGICAL INFORMATION11.1 Information on toxicological effectsAcute toxicityClassified based on available data. For more details, see section 2Skin corrosion/irritationClassified based on available data. For more details, see section 2Serious eye damage/irritationClassified based on available data. For more details, see section 2Respiratory or skin sensitizationClassified based on available data. For more details, see section 2Germ cell mutagenicityClassified based on available data. For more details, see section 2CarcinogenicityIARC: No component of this product present at a level equal to or greater than 0.1% is identified as probable, possible or confirmed human carcinogen by IARC.ACGIH: No component of this product present at a level equal to or greater than 0.1% is identified as a potential or confirmed carcinogen by ACGIH.NTP: No component of this product present at a level equal to or greater than 0.1% is identified as a anticipated or confirmed carcinogen by NTP.OSHA: No component of this product present at a level equal to or greater than 0.1% is identified as a potential or confirmed carcinogen by OSHA.Reproductive toxicityClassified based on available data. For more details, see section 2Specific target organ toxicity - single exposureClassified based on available data. For more details, see section 2Specific target organ toxicity - repeated exposureClassified based on available data. For more details, see section 2Aspiration hazardClassified based on available data. For more details, see section 212. ECOLOGICAL INFORMATION12.1 ToxicityNo data available.12.2 Persistence and degradabilityNo data available.12.3 Bioaccumlative potentialNo data available.12.4 Mobility in soilNo data available.12.5 Results of PBT and vPvB assessmentPBT/vPvB assessment unavailable as chemical safety assessment not required or not conducted.12.6 Other adverse effectsNo data available.13. DISPOSAL CONSIDERATIONS13.1 Waste treatment methodsProductDispose substance in accordance with prevailing country, federal, state and local regulations.Contaminated packagingConduct recycling or disposal in accordance with prevailing country, federal, state and local regulations.14. TRANSPORT INFORMATIONDOT (US)This substance is considered to be non-hazardous for transport.IMDGThis substance is considered to be non-hazardous for transport.IATAThis substance is considered to be non-hazardous for transport.15. REGULATORY INFORMATIONSARA 302 Components:No chemicals in this material are subject to the reporting requirements of SARA Title III, Section 302.SARA 313 Components:This material does not contain any chemical components with known CAS numbers that exceed the threshold (De Minimis) reporting levels established by SARA Title III, Section 313.SARA 311/312 Hazards:No SARA Hazards.Massachusetts Right To Know Components:No components are subject to the Massachusetts Right to Know Act.Pennsylvania Right To Know Components:No components are subject to the Pennsylvania Right to Know Act.New Jersey Right To Know Components:No components are subject to the New Jersey Right to Know Act.California Prop. 65 Components:This product does not contain any chemicals known to State of California to cause cancer, birth defects, or anyother reproductive harm.16. OTHER INFORMATIONCopyright 2017 MedChemExpress. The above information is correct to the best of our present knowledge but does not purport to be all inclusive and should be used only as a guide. The product is for research use only and for experienced personnel. It must only be handled by suitably qualified experienced scientists in appropriately equipped and authorized facilities. The burden of safe use of this material rests entirely with the user. MedChemExpress disclaims all liability for any damage resulting from handling or from contact with this product.Caution: Product has not been fully validated for medical applications. For research use only.Tel: 609-228-6898 Fax: 609-228-5909 E-mail: tech@Address: 1 Deer Park Dr, Suite Q, Monmouth Junction, NJ 08852, USA。

RP-HPLC法测定栀榆洗剂中栀子苷含量

RP-HPLC法测定栀榆洗剂中栀子苷含量作者：许庆荀秀彪肖植国来源：《医学信息》2020年第14期摘要：目的; 建立反向高效液相色谱法（RP-HPLC）测定栀榆洗剂中栀子苷的含量。

方法; 采用反相高效液相色谱法进行测定，色谱柱为十八烷基键合硅胶柱（Agilent Eclipse pius C18色谱柱，4.6×250 mm，5μm）;流动相为甲醇-水（5∶95）进行梯度洗脱，流速为1.0 ml/min;色谱柱温：30 ℃;检测器检测波长：238 nm。

结果; 栀子苷浓度在22.4～168.0 μg/ml时与峰面积呈良好线性关系，r=0.9999，平均回收率为97.44%（RSD为1.27%）。

结论; 本次建立的方法准确、快速、简便可靠，结果稳定，可用于栀榆洗剂中栀子苷的含量测定。

关键词：栀榆洗剂;栀子苷;高效液相色谱法中图分类号：R29; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;文獻标识码：A; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;DOI：10.3969/j.issn.1006-1959.2020.14.059文章编号：1006-1959（2020）14-0177-03Determination of Jasminoidin in Zhiyu Lotion by RP-HPLCXU Qing，XUN Xiu-biao，XIAO Zhi-guo（Qujing Food and Drug Inspection and Testing Center，Qujing 655000，Yunnan，China）Abstract：Objective; To establish a reverse high performance liquid chromatography （RP-HPLC） method for the determination of jasminoidin in Zhiyu lotion.Methods; The chromatographic column was octadecyl bonded silica gel column （Agilent Eclipse pius C18 column ，4.6 mm×250 mm，5μm）， the mobile phase was methanol-water （5∶95） for gradient elution， the flow rate was 1.0 ml/min; chromatographic column temperature ：30℃ detection wavelength ：238nm.Results; The concentration of jasminoidin showed a good linear relationship with the peak area at 22.4～168.0 μg/ml， r=0.9999， and the average recovery rate was 97.44% （RSD was1.27%）.Conclusion; The established method is accurate， rapid， simple and reliable， and the results are stable. It can be used to determine the content of jasminoidin in the lotion.Key words：Zhiyu lotion;Jasminoidin;HPLC栀榆洗剂是曲靖市中医医院研制的制剂，由栀子、地榆、马齿苋、苦参、大黄、白鲜皮、地肤子、豨莶草、荆芥、防风、白矾11种中药组成，具有清热解毒凉血、祛风燥湿止痒。

碧云天 BeyoPure

BeyoPure™ YPD Broth (premixed powder)产品编号产品名称包装ST961-5LBeyoPure™ YPD Broth (premixed powder)10×500ml产品简介：碧云天生产的BeyoPure™ YPD Broth (premixed powder)，即BeyoPure™ YPD培养基(预混粉末)，即酵母膏蛋白胨葡萄糖培养基(Yeast Extract Peptone Dextrose Medium)预混粉末，简称YPD或YEPD预混粉末，也称酵母浸出粉蛋白胨葡萄糖培养基预混粉末，是一种由高纯度高质量的酵母提取物(Yeast extract)、和大豆蛋白胨(Peptone)和葡萄糖(Dextrose)均匀混合而成的用于酵母培养的完全培养基预混粉末。

本产品使用时无需称量，每瓶或每两瓶本产品直接加入500ml或1L超纯水、去离子水或蒸馏水，无须溶解，直接121ºC高压灭菌15分钟，就可以制备成YPD液体培养基，可用于后续酵母等的培养。

每瓶本产品中含有高纯度高质量的酵母膏5g、大豆蛋白胨10g 和葡萄糖10g，具体可以参考下表。

Reagent Amount (g/bottle for 500ml)Yeast extract 5Peptone10 Dextrose (D-glucose)10 YPD培养基属于非选择性酵母培养基(Non-selective isolation medium)，非常适合酿酒酵母属、毕赤酵母属、接合酵母属、假丝酵母属的培养，常用于分子克隆、蛋白质表达或菌株培养等实验。

本YPD培养基支持大多数异养微生物的生长，培养基中的蛋白胨提供氮营养，酵母提取物提供含氮营养物质以及维生素B等，葡萄糖为酵母的生长提供碳水化合物和能量来源。

由于培养基组成简单，一般被用作酵母常规培养的基础培养基。

一个包装的本产品，共可以配制5L YPD液体培养基。

依达拉奉右莰醇通过铁死亡-脂质过氧化通路对脑出血大鼠神经保护的作用机制

实验研究依达拉奉右莰醇通过铁死亡-脂质过氧化通路对脑出血大鼠神经保护的作用机制毛权西，李作孝△摘要：目的探讨依达拉奉右莰醇对脑出血大鼠的神经保护作用及血肿周围脑组织脂质过氧化的影响。

方法将128只SD大鼠随机分为假手术组、脑出血组、依达拉奉组和依达拉奉右莰醇组，每组32只。

除假手术组外，其余组大鼠构建急性脑出血模型，依达拉奉组、依达拉奉右莰醇组于造模后分别腹腔注射依达拉奉6mg/kg、依达拉奉右莰醇7.5mg/kg，每12h注射1次，假手术组和脑出血组腹腔注射等量生理盐水。

术后1d、3d、7d和14d按Garcia评分标准进行神经功能评分，HE染色观察血肿周围脑组织病理变化，化学荧光法检测血肿周围脑组织活性氧（ROS）含量，微量酶标法检测血肿周围脑组织还原型谷胱甘肽（GSH）含量，蛋白免疫印迹法检测血肿周围脑组织谷胱甘肽过氧化物酶4（GPX4）、长链脂酰辅酶A合成酶4（ACSL4）和磷脂胆碱酰基转移酶3（LPCAT3）表达。

结果与假手术组比较，脑出血组大鼠神经功能评分降低，血肿周围脑组织出现大量炎性细胞浸润及神经细胞变性，ROS含量、ACSL4和LPCAT3蛋白表达水平升高，GSH含量、GPX4蛋白表达水平降低（P＜0.05）；与脑出血组比较，依达拉奉组和依达拉奉右莰醇组大鼠神经功能评分升高，血肿周围脑组织病理损伤明显减轻，ROS含量、ACSL4和LPCAT3蛋白表达水平降低，GSH含量、GPX4蛋白表达水平增加（P＜0.05）；依达拉奉右莰醇组干预效果优于依达拉奉组（P＜0.05）；除假手术组外，其余各组均在术后3d时变化最明显，术后7d、14d逐渐恢复（P＜0.05）。

结论依达拉奉右莰醇可能通过调节脑出血大鼠神经细胞铁死亡相关蛋白的表达，减少脑组织脂质过氧化，抑制神经细胞铁死亡，从而发挥脑保护作用。

关键词：依达拉奉右莰醇；依达拉奉；脑出血；铁死亡；脂质过氧化中图分类号：R743.34文献标志码：A DOI：10.11958/20221777Neuroprotective mechanism of edaravone dexborneol in rats with cerebral hemorrhage throughferroptosis-lipid peroxidation pathwayMAO Quanxi,LI Zuoxiao△Department of Neurology,the Affiliated Hospital of Southwest Medical University,Luzhou646000,China△Corresponding Author E-mail:Abstract:Objective To investigate the neuroprotective effect of edaravone dexborneol on cerebral hemorrhage in rats and the effect of lipid peroxidation on perihematomal brain tissue.Methods A total of128SD rats were randomly divided into the sham-operated group,the cerebral hemorrhage group,the edaravone group and the edaravone dexborneol group, with32rats in each group.The acute cerebral hemorrhage model was constructed in all groups except for the sham-operated group.The edaravone group and edaravone dexamphene group were injected intraperitoneally with6mg/kg of edaravone and edaravone dexamphene7.5mg/kg,one injection every12hours.The sham-operated group and the cerebral hemorrhage group were injected intraperitoneally with equal amounts of saline.The neurological function was scored according to Garcia score at1d,3d,7d,and14d after surgery.Brain tissue around hematoma was stained with HE staining.Chemo fluorescence assay was used to observe pathological changes and reactive oxygen species(ROS)content of brain tissue around hematoma.Micro enzyme labeling assay was used to detect glutathione(GSH)content of brain tissue around hematoma.The expression levels of glutathione peroxidase4(GPX4),long-chain lipid acyl-coenzyme A synthase4(ACSL4) and phospholipid choline acyltransferase3(LPCAT3)in brain tissue around hematoma were detected by protein immunoblotting.Results Compared with the sham-operated group,neurological function scores were decreased in the cerebral hemorrhage group.Massive inflammatory cell infiltration and neuronal degeneration in brain tissue around hematoma were found,and ROS content,ACSL4and LPCAT3protein expression level increased.GSH content and GPX4 protein expression level decreased in the cerebral hemorrhage group(P＜0.05).Compared with the cerebral hemorrhage group,neurological function scores were increased,histopathological damage around the hematoma was significantly基金项目：泸州市人民政府-西南医科大学科技战略合作基金项目（2018LZXNYD-ZK17）作者单位：西南医科大学附属医院神经内科（邮编646000）作者简介：毛权西（1990），男，硕士在读，主要从事神经免疫方向研究。

TAK-875_DataSheet_MedChemExpress

Inhibitors, Agonists, Screening Libraries Data SheetBIOLOGICAL ACTIVITY:TAK–875 is a potent, selective and orally bioavailable GPR40 agonist with EC 50 of 72 nM.IC50 & Target: EC50: 72 nM (GPR40)In Vitro: TAK–875 (0.01–10 μM) produces a concentration–dependent increase in intracellular IP production in CHO–hGPR40, with EC 50of 0.072 μM. TAK–875 (0.1–10 μM) dose–dependently augments intracellular IP production in CHO cells [1]. TAK–875 (3–30 μM)concentration–dependently augments [Ca 2+]i . In the presence of 10 mM glucose, TAK–875 (0.001–10 μM) dose–dependently stimulats insulin secretion from INS–1 833/15 cells [2].In Vivo: TAK–875 (10 mg/kg, p.o.) increases plasma insulin levels in ZDF rats. TAK–875 (30 mg/kg, p.o.) improves fasting hyperglycemia without affecting fasting normoglycemia. TAK–875 at 30 mg/kg, which is a 3– to 10–fold higher dose compared with the dose that improved glucose tolerance in diabetic rats, does not alter fasting glucose levels in SD rats with normal glucose homeostasis. Likewise,TAK–875 does not significantly alter insulin secretion in SD rats with normal fasting glucose levels [1].PROTOCOL (Extracted from published papers and Only for reference)Kinase Assay:[1]INS–1 832/13 cells are suspended in RPMI medium containing 11 mM glucose and the supplementsdescribed above. These cells are seeded at a density of 2×104 cells/well in a 96–well black plate coated with poly–D–lysine, and 1%BSA and 0.1% DMSO alone (control), palmitic acid (62.5, 125, 250, 500, and 1000 μM), oleic acid (62.5, 125, 250, 500, and 1000 μM), or TAK–875 (6.25, 12.5, 25, 50, and 100 μM) is added to the plate with 1% BSA and 0.1% DMSO, followed by culture for 72 h. After the culture, caspase 3/7 activity is measured with the Apo–one homogeneous caspase 3/7 assay according to the manufacturer's instructions. Fluorescence intensity is measured at an excitation of 485 nm and an emission at 535 nm.Cell Assay: TAK–875 is dissolved in 1% BSA and 0.1% DMSO. [1]INS–1 832/13 cells are suspended in RPMI medium and seeded in a 96–well plate at a density of 2×104 cells/well; 1% BSA and 0.1% DMSO alone (control), palmitic acid (10, 100, and 1000 μM), oleic acid (10, 100, and 1000 μM), or TAK–875 (1, 10, and 100 μM) is added to the plate. After 72–h culture, medium is discarded, and cells are preincubated for 2 h with KRBH containing 1 mM glucose and 0.2% BSA at 37°C. After discarding of the preincubation buffer, KRBH containing 1 or 20 mM glucose and 0.2% BSA is added, and the plate is further incubated for 2 h. The insulin concentration in the supernatant is measured as described above. To measure intracellular insulin content, INS–1 832/13 cells are exposed to 1% BSA and 0.1% DMSO alone (control), palmitic acid (1000 μM), oleic acid (1000 μM), or TAK–875 (100 μM) with 1% BSA and 0.1% DMSO. After incubation, cells are washed once with phosphate–buffered saline, and acid–ethanol solution is added to each well, followed by sonication on ice. Intracellular insulin is extracted by overnight incubation at -30°C, followed by separation of supernatant by centrifugation at 12,000 rpm×5 min at 4°C.Animal Administration: TAK–875 is formulated in 0.5% methylcellulose.[1]At 18 weeks of age, the N–STZ–1.5 rats are fasted overnight and orally given vehicle (0.5% methylcellulose) or TAK–875 (1, 3, and 10 mg/kg). Sixty minutes later, all animals receive an oral glucoseProduct Name:TAK–875Cat. No.:HY-10480CAS No.:1000413-72-8Molecular Formula:C 29H 32O 7S Molecular Weight:524.63Target:GPR40Pathway:GPCR/G Protein Solubility:DMSO: ≥ 128 mg/mLload (1 g/kg). Blood samples are collected from the tail vein before drug administration, before glucose load (time 0), and 10, 30, 60, and 120 min after the glucose load. Plasma glucose and insulin levels are measured with an AutoAnalyzer 7080 and radioimmunoassay, respectively. To see the effects of TAK–875 on fasting normoglycemia and hyperglycemia, SD rats (8 weeks old) or ZDF and ZL rats (12 weeks old) are fasted overnight and orally given vehicle (0.5% methylcellulose), TAK–875 (10 or 30 mg/kg), nateglinide (50 mg/kg), or glibenclamide (10 mg/kg). Blood samples are collected from the tail vein before drug administration (time 0) and 0.5, 1, 2, and 3 h (SD rats) and 0.5, 1, 2, 4, and 6 h (ZDF and ZL rats) after drug administration, and plasma glucose and insulin levels are measured as described above.References:[1]. Tsujihata Y,et al. TAK–875, an orally available G protein–coupled receptor 40/free fatty acid receptor 1 agonist, enhances glucose–dependent insulin secretion and improves both postprandial and fasting hyperglycemia in type 2 diabetic rats.J Pharmacol Exp[2]. Yoshiyuki Tsujihata, et al. TAK–875, an Orally Available GPR40/FFA1 Agonist Enhances Glucose–Dependent Insulin Secretion and Improves Both Postprandial and Fasting Hyperglycemia in Type 2 Diabetic Rats. JPET July 13, 2011Caution: Product has not been fully validated for medical applications. For research use only.Tel: 609-228-6898 Fax: 609-228-5909 E-mail: tech@Address: 1 Deer Park Dr, Suite Q, Monmouth Junction, NJ 08852, USA。

进口器械耗材试剂目录表1

1.乳酸脱氢酶试剂盒 (Siemens Medical Solutions Diagnostics 国食药监械(进)字2002.肌酸激酶试剂盒 (Siemens Medical Solutions Diagnostics 国食药监械(进)字2004第3400291号(更3.碱性磷酸酶试剂盒 (Siemens Medical Solutions Diagnostics 国食药监械(进)字2004第3400293号(4.丙氨酸氨基转移酶试剂盒 (Siemens Medical Solutions Diagnostics 国食药监械(进)字2004第34005.淀粉酶试剂盒 (Siemens Medical Solutions Diagnostics 国食药监械(进)字2004第3400294号(更))6.CD45RO-PE荧光单克隆抗体试剂 (法国 IMMUNOTECH S.A.S （美国贝克曼库尔特有限公司分公司）国7.CD3-FITC/CD(16+56)-PE荧光单克隆抗体试剂 (法国 IMMUNOTECH S.A.S （美国贝克曼库尔特有限公司8.CD45RA-FITC荧光单克隆抗体试剂 (法国 IMMUNOTECH S.A.S （美国贝克曼库尔特有限公司分公司）9.ISE－缓冲液 (Siemens Medical Solutions Diagnostics 国食药监械(进)字2004第3400162号(更))10.稀释液 ( 国食药监械（进）字2007第3400992号)11.质控品 (美国SYSMEX CORPORATION希森美康株式会社国食药监械（进）字2007第3400993号)12.质控品 (美国 SYSMEX CORPORATION希森美康株式会社国食药监械（进）字2007第3400994号)13.皮质醇试剂包 ( 国食药监械（进）字2007第3401009号)14.三碘甲状腺原氨酸摄取试剂包 (Ortho-Clinical Diagnostics Inc., 国食药监械（进）字2007第3415.肌酸激酶MB亚单位质量试剂包 ( 国食药监械（进）字2007第3401011号)16.采血针 (德国罗氏诊断有限公司国食药监械（进）字2007第3410922号)17.苯妥英试剂盒 ( 国食药监械(进)字2005第3401316号(更))18.凝血酶原时间测试试剂 (德国 Dade Behring Marburg公司国食药监械（进）字2007第3400990号)19.GPA-PE荧光单克隆抗体试剂 (法国 IMMUNOTECH S.A.S （美国贝克曼库尔特有限公司分公司）国食20.腔镜手助器(商品名：兰碟斯) (Hakko Co., Ltd. 国食药监械(进)字2007第3660631号)21.高压注射连接管 (美国 Argon Medical Devices, Inc 国食药监械(进)字2007第3660652号)22.球囊扩张导管(商品名：Extensor) ( 国食药监械(进)字2007第3770536号)23.弹簧圈(商品名：GDC) (Boston Scientific Corporation 国食药监械(进)字2007第3770569号)24.穿刺导引套装英文名称：Exacta Percutaneous Sheath Introducer Kits (Becton Dickinson Cri25.7.382缓冲液 ( 国食药监械(进)字2004第3401401号(更))26.尿液总蛋白试剂盒 ( 国食药监械(进)字2005第3401707号(更))27.网织红细胞稀释液·染色液 (日本 SYSMEX CORPORATION希森美康株式会社国食药监械（进）字20028.肺通气功能测定仪(商品名：肺功能仪) (日本福田产业株式会社国食药监械(进)字2007第2400718号29.高密度脂质胆固醇诊断试剂盒 (日本协和医药株式会社国食药监械(进)字2007第2400722号)30.白蛋白检测试剂盒 (西班牙博士泰公司国食药监械(进)字2007第2400723号)31.镁检测试剂盒 (西班牙博士泰公司国食药监械(进)字2007第2400724号)32.葡萄糖检测试剂盒 (西班牙博士泰公司国食药监械(进)字2007第2400725号)33.HL-9000/IONEA型高电位治疗器 (株式会社日本医疗科学国药管械(进)2002第2210693号(更))34.BIO 2001 生殖泌尿系统生物反馈电刺激治疗仪 (METRASOL公司国食药监械(进)字2004第3260453号35.CD3-FITC荧光单克隆抗体试剂 (法国 IMMUNOTECH S.A.S （美国贝克曼库尔特有限公司分公司）国36.CD38-FITC荧光单克隆抗体试剂 (法国 IMMUNOTECH S.A.S （美国贝克曼库尔特有限公司分公司）国37.胰淀粉酶测定试剂盒 (关东化学株式会社国食药监械(进)字2007第2400711号)38.类风湿因子诊断试剂盒 ( 国食药监械(进)字2005第3401715号(更))39.前白蛋白诊断试剂盒 (Siemens Medical Solutions Diagnostics 国食药监械(进)字2005第240145140.组织脱水机(商品名：珊顿组织脱水机) (美国 Thermo Electron Corporation 国食药监械(进)字2041.切片机(商品名：珊顿冷冻切片机) (美国 Thermo Electron Corporation 国食药监械(进)字2007第42.组织脱水机(商品名：珊顿全密封组织脱水机) (美国 Thermo Electron Corporation 国食药监械(进43.呼吸球及附件 (VBM Medizintechnik GmbH 国食药监械(进)字2007第1540638号)44.麻醉面罩 (Mallinckrodt Dar S.r.l. 国食药监械(进)字2007第1540643号)45.牙科种植体手术工具 (MegaGen Co.,Ltd. 国食药监械(进)字2007第1550546号)46.酒精诊断试剂盒 (德国罗氏诊断有限公司国食药监械(进)字2007第3400693号)47.转铁蛋白诊断试剂盒 ( 国食药监械(进)字2005第3401771号(更))48.全段甲状旁腺激素试剂盒 ( 国食药监械(进)字2006第3401974号(更))49.全自动荧光磁微粒酶免分析仪 (日本东曹株式会社日本东曹株式会社国食药监械(进)字2007第240050.化学发光分析仪 (德国 DiaSorin Deutschland GmbH 国食药监械(进)字2007第2400559号)51.丙氨酸氨基转移酶试剂盒 (Dade Behring Inc. 国食药监械(进)字2007第2400705号)52.低密度脂质胆固醇诊断试剂盒 (协和医药株式会社国食药监械(进)字2007第2400708号)53.甘油三酯诊断试剂盒 (协和医药株式会社国食药监械(进)字2007第2400709号)54.手术膜 (美国 3M Company3M Company 国食药监械(进)字2007第2640542号)55.高密度/低密度胆固醇校准液 ( 国食药监械(进)字2005第3402329号(更))56.通用稀释液8 ( 国食药监械(进)字2005第3401703号(更))57.植入式心脏起搏器 (美国 Guidant Corporation Cardiac Pacemakers Inc. 国食药监械(进)字200658.通用稀释液1 ( 国食药监械(进)字2005第3401697号(更))59.中空螺钉(商品名：Magana-Fx内固定中空螺钉) (美国 Zimmer Inc. 捷迈公司国食药60.带锁髓内钉(商品名：M/DN) (美国 Zimmer Inc. 捷迈公司国食药监械（进）字2007第3461044号)61.全髋关节系统(商品名：Elite Plus) (英国 DePuy International Ltd 国食药监械（进）字2007第62.内固定线缆系统(商品名：ATLAS) (美国 Medtronic Sofamor Danek USA Inc. 国食药监械（进）字63.髋关节假体(商品名：VerSys推荐型髋关节假体) (美国 Zimmer Inc. 捷迈公司国食药监械（进）字64.鼻塞(商品名：Raucocel 鼻塞) (（Deutschland）Lohmann & Rauscher 国际股份有限公司国食药监65.腹腔镜及附件(商品名：腹腔镜及附件) (奥林巴斯苇音特和意北公司国食药监械(进)字2007第322066.Acculan电池动力系统 (Aesculap AG & Co. KG 国食药监械(进)字2004第2211422号(更))67.透析用碳酸氢钠干粉 (B. Braun Medizintechnologie GmbH 国食药监械(进)字2004第3451444号(更68.二氧化碳校准液/稀释液 (Siemens Medical Solutions Diagnostics 国食药监械(进)字2005第340269.乙烯基聚硅氧烷咬合检测印模材料(商品名:而至精确咬合记录II型) (日本株式会社而至国食药监械70.用于口腔粘膜的亲水乙烯基聚硅氧烷印模材料(商品名:而至精确义齿记录) (日本株式会社而至国食71.而至快速自凝基托树脂 (株式会社而至国食药监械(进)字2005第3632051号(更))72.而至义齿贴合点指示剂 (而至株式会社国食药监械(进)字2005第2633109号(更))73.胰岛素校准液 ( 国食药监械(进)字2005第3402318号(更))74.通用稀释液10 ( 国食药监械(进)字2005第3401704号(更))75.铜蓝蛋白试剂盒 (英国 THE BINDING SITE公司国食药监械(进)字2007第3400649号)76.补体C4试剂盒 (The Binding Site Limited 国食药监械(进)字2007第3400650号)77.气动动力系统 (Aesculap AG & CO.KG 国食药监械(进)字2005第2541844号(更))78.避孕套 (马来西亚康乐工业有限公司国食药监械(进)字2006第3661816号(更))79.导引导管 (Boston Scientific Corporation 国食药监械(进)字2005第3773129号(更))80.Cardio MD（单光子发射计算机断层）伽玛相机系统 (ADAC Laboratories A Philips Medical Syst81.全自动组织脱水机 (德国徕卡仪器公司Leica Microsystems Nussloch GmbH 国食药监械(进)字200382.耐甲氧西林金黄色葡萄球菌鉴定培养基 (bioMerieux,sa 国食药监械(进)字2006第3400205号(更))83.洗脱缓冲液 (日本 TOSOH CORPORATION 国食药监械（进）字2007第3400983号)84.C反应蛋白校准品 ( 国食药监械（进）字2007第3400985号)85.胆红素定标品 ( 国食药监械（进）字2007第3400986号)86.脂类定标品 (SYSMEX CORPORATION 国食药监械（进）字2007第3400987号)87.质控品 ( 国食药监械（进）字2007第3400988号)88.糖化血清蛋白测定试剂盒（生化酶法） (英国 Genzyme Diagnostic 国食药监械（进）字2007第34089.高频电烧装置 (日本奥林巴斯医疗株式会社 OLYMPUS MEDICAL SYSTEMS CORP. 国食药监械(进)字290.正电子发射及计算机断层扫描系统 (美国 Siemens Medical Solutions USA,Inc 国食药监械(进)字91.荧光探针脱氧核糖核酸检测系统 (美国 Becton,Dickinsonand Company公司国食药监械(进)字200792.促肾上腺皮质激素定标液 (Roche Diagnostics GmbH 国食药监械(进)字2007第3400501号)93.水杨酸盐试剂盒 (Dade Behring, Inc. 国食药监械(进)字2007第3400646号)94.叶酸诊断试剂盒 (德国罗氏诊断有限公司Roche Diagnostics GmbH 国食药监械(进)字2007第3400695.免疫球蛋白M试剂盒 (The Binding Site Limited 国食药监械(进)字2007第3400648号)96.一次性胰岛素注射器带针头 ( 国食药监械(进)字2004第3152002号(更))97.带恒速调节器的输液管路 (Baxter S.A. 国食药监械(进)字2004第3661717号(更))98.百耐凝胶（Bionect gel） (意大利 Fidia制药厂国食药监械(进)字2005第2640099号(更))99.自粘性硅胶片(商品名：仙卡) (Smith & Nephew Medical Ltd. 国食药监械(进)字2007第2660635号100.一次性使用真空采血管 (Greiner Bio-One Gmbh 国食药监械(进)字2007第2660642号)101.喉罩导气管 (塞舌尔 The Laryngeal Mask Company Limited 国食药监械(进)字2007第2660719号) 102.甲状腺过氧化酶自身抗体试剂盒 (Siemens Medical Solutions Diagnostics 国食药监械(进)字20 103.通用稀释液7 ( 国食药监械(进)字2005第3401702号(更))104.X射线摄影暗匣(商品名：柯达 X-OMAT 暗盒) (美国 EASTMAN KODAK COMPANYEASTMAN KODAK COMPA 105.电解质参比液 (德国罗氏诊断有限公司国食药监械(进)字2007第1400716号)106.诱导剂 (芬兰 PerkinElmer Life and Analytical Sciences，Wallac Oy 国食药监械(进)字2007第107.甲状腺球蛋白试剂盒 (Siemens Medical Solutions Diagnostics 国食药监械(进)字2004第340054108.甲状腺过氧化物酶抗体试剂盒 (Siemens Medical Solutions Diagnostics 国食药监械(进)字2004 109.四碘甲状腺原氨酸试剂盒 (Siemens Medical Solutions Diagnostics 国食药监械(进)字2004第34 110.植入式心脏起搏器 (美国 Guidant Corporation Cardiac Pacemakers Inc. 国食药监械(进)字200 111.超声诊断系统和探头 (Philips Ultrasound, INC. 国食药监械(进)字2004第3230502号(更))112.血糖监测仪 (Infopia CO.,Ltd. 国食药监械(进)字2005第2402628号(更))113.血糖试条 (Infopia Co.,Ltd 国食药监械(进)字2005第2402611号(更))114.低温等离子体灭菌器 ( 国食药监械(进)字2005第2571415号(更))115.地高辛试剂盒 ( 国食药监械(进)字2005第3401304号(更))116.万古霉素试剂盒 ( 国食药监械(进)字2005第3401383号(更))117.卡马西平试剂盒 ( 国食药监械(进)字2005第3401379号(更))118.高频电外手科术和电凝设备(商品名：VIO系列高频电外科系统) (德国爱尔博电子医疗仪器公司国119.肺炎链球菌抗生素敏感实验用抗生素 (美国 biomerieux,Inc. 国食药监械(进)字2007第3400685号120.维生素B12试剂盒 ( 国食药监械(进)字2005第3401380号(更)121.白蛋白试剂盒Albumin (Siemens Medical Solutions Diagnostics 国食药监械(进)字2004第34001 122.甘油三酯试剂盒 (Siemens Medical Solutions Diagnostics 国食药监械(进)字2004第3400140号( 123.齿科烤瓷合金(商品名：Ceradelta 2) (Metalor Technologies SA 国食药监械(进)字2007第26306124.排龈膏 (法国 Produits Dentaires Pierre Rolland SAS,Acteon Pharma Division 国食药监械(进125.烤瓷瓷粉(商品名：烤瓷瓷粉) (德国 Hager & Werken GmbH & Co.，KG 国食药监械(进)字2007第2 126.医疗压力带(商品名：医疗压力带) (LABORATORI PIAZZA S.r.l. 国食药监械(进)字2007第2640509 127.藻酸钙止血贴 (美国 TZ Medical Inc.TZ Medical Inc. 国食药监械(进)字2007第2640512号) 128.抗核抗体谱(IgG)检测试剂盒(欧蒙印迹法) (德国 EUROIMMUN Medizinische Labordiagnostika AG 129.医用诊断X射线管组件 (美国 Varian Medical Systems 国食药监械(进)字2007第2310622号)130.血糖仪 (韩国 i-SENS.Inc 国食药监械(进)字2007第2400442号)131.尿液分析仪 (盈东电子株式会社国食药监械(进)字2007第2400447号)132.碳13红外光谱仪 (日本大塚电子株式会社国食药监械(进)字2007第2400451号)133.血糖检测系统(商品名：罗康全优越型) (德国罗氏诊断有限公司国食药监械(进)字2007第240045 134.半自动血凝分析仪 (德国　MERLIN medical GmbH 国食药监械(进)字2007第2400476号)135.疝环充填补片(商品名：巴德) (美国 Davol Inc.,Subsidiary of C.R. Bard,Inc. 国食药监械(进 136.疝修补平片和预裁补片(商品名：巴德) (美国 Davol Inc.,Subsidiary of C.R. Bard,Inc. 国食137.切口疝补片(商品名：巴德) (美国 Davol Inc.,Subsidiary of C.R. Bard,Inc. 国食药监械(进)字138.348 Hct Slope 试剂盒 ( 国食药监械(进)字2004第3401406号(更))139.6.838缓冲液 ( 国食药监械(进)字2004第3401410号(更))140.病人固定系统(商品名：UON-DUON) (比利时 ORFIT INDUSTRIES N.V 国食药监械(进)字2007第1100 141.病人固定系统(商品名：EFFICAST) (比利时 ORFIT Industries N.V 国食药监械(进)字2007第1100 142.病人固定系统(商品名：AIO Solution) (比利时 ORFIT INDUSTRIES N.V 国食药监械(进)字2007第143.矫形外科（骨科）手术器械 (奥地利 I.T.S Implantat-Technologie Systeme GmbH 国食药监械(进144.椎间融合器安装工具(商品名：椎间融合器安装工具) (俄罗斯《KIMPF》股份有限公司 Closedjoi 145.组件式短柄假体工具(商品名：Metha) (AESCULAP AG & CO.KG 国食药监械(进)字2007第1100568号146.矫形外科手术器械 (韩国GS医疗公司GS Medical 国食药监械(进)字2007第1100706号)147.医用干式胶片(商品名：富士) (日本 Fuji Photo Film Co.,Ltd 国食药监械(进)字2007第1240484 148.接骨板和接骨螺钉(商品名：LINK 接骨板和接骨螺钉系统) ( 国食药监械（进）字2007第3461012号149.机械心脏瓣膜(商品名：Regent) (美国圣犹达医疗用品有限公司国食药监械（进）字2007第3461 150.血气分析仪 (Siemens Medical Solutions Diagnostics 国食药监械(进)字2004第2401337号(更)) 151.血气分析仪 (英国 Siemens Medical Solutions Diagnostics Manufacturing Limited 国食药监152.危重症检测分析仪系列 ( 国食药监械(进)字2006第2210279号(更))153.348 Buffer Pack 试剂盒 ( 国食药监械(进)字2004第3401443号(更))154.348/248冲洗液试剂盒 ( 国食药监械(进)字2004第3401531号(更))155.玻璃离子水门汀(商品名：FUJI PLUS) (日本　株式会社而至国食药监械(进)字2006第3631801号(156.乙烯基聚硅氧烷印模材料(膏剂型)(商品名：而至精确硅橡胶膏剂型) (株式会社而至国食药监械157.球囊预装支架传送系统(商品名：TriMaxx 冠状动脉预装支架传送系统) (美国 Abbott Vascular D 158.导丝(商品名：HiWire) (美国库克泌尿外科公司；Cook Urological Incorporated 国食药监械(进159.导引导管(商品名：Launcher) (Medtronic, Inc. 国食药监械(进)字2007第3770627号)160.护套介入系统(商品名：Brite Tip) (Cordis Corporation 国食药监械(进)字2007第3770629号) 161.革兰氏阴性细菌药敏实验用抗生素 (美国 biomerieux,Inc. 国食药监械(进)字2007第3400686号) 162.皮质醇试剂盒 (美国 Bayer HealthCare LLC 国食药监械(进)字2007第3400687号)163.系列冲洗液/废液试剂盒 (美国 Siemens Medical Solutions Diagnostics 国食药监械(进)字2007 164.测量试剂盒 (美国 Siemens Medical Solutions Diagnostics 国食药监械(进)字2007第3400689号165.便潜血测定试剂盒 (日本株式会社常光国食药监械(进)字2007第3400690号)166.肌钙蛋白－I测定试剂盒 (日本株式会社常光国食药监械(进)字2007第3400691号)167.肌红蛋白测定试剂盒 (日本株式会社常光国食药监械(进)字2007第3400692号)168.穆法 MV 呼吸机 (G.LOHMEIER GmbH 国食药监械(进)字2005第3541326号(更))169.全自动蛋白印迹仪 (Genelabs Diagnostics Pte. Ltd. 国食药监械(进)字2005第3402673号(更)) 170.泌尿系统致病菌鉴定培养基 (bioMerieux,sa 国食药监械(进)字2005第3403472号(更))171.庆大霉素试剂盒 ( 国食药监械(进)字2005第3401378号(更))172.髋部螺钉系统(商品名：亚洲型) (美国 Smith & Nephew, Inc. Orthopaedic Division 国食药监械173.肌酸激酶MB同工酶校准液 ( 国食药监械(进)字2005第3401797号(更))174.移动式X射线诊断设备 (Siemens AG 国食药监械(进)字2007第2300704号)175.影像板扫描处理系统(商品名：柯达 Point-of-Care CR 系统) (美国 Eastman Kodak Company 国食176.X射线口内影像系统 (韩国 VATECH Co.Ltd. 国食药监械(进)字2007第2310517号)177.血液透析用管道Lines for hemodialysis (Gambro DASCO S.p.A 国食药监械（进）字2007第34507 178.管路及滤器H.E.L.P. Consumables (德国 B.Braun Medizintechnologie GmbH 国食药监械（进）字179.血浆分离器(商品名：Haemoselect) (德国 B. Braun Medizintechnologie GmbH 国食药监械（进）180.补体C3诊断试剂盒 (Siemens Medical Solutions Diagnostics 国食药监械(进)字2005第3401775号181.可吸收骨替代材料（商品名：固骼生） (美国诺邦生物制品有限公司国食药监械(进)字2004第346 182.尿分析阳性和阴性质控试纸 ( 国食药监械(进)字2006第3401062号(更))183.尿液分析仪 (Siemens Medical Solutions Diagnostics 国食药监械(进)字2004第2401280号(更)) 184.尿液分析仪 (Siemens Medical Solutions Diagnostics 国食药监械(进)字2004第2402147号(更)) 185.校准液C ( 国食药监械(进)字2005第3401788号(更))186.校准液B ( 国食药监械(进)字2005第3401800号(更))187.校准液A ( 国食药监械(进)字2005第3401787号(更))188.C反应蛋白（Ⅱ）乳胶试剂盒X2 (日本 DENKA SEIKEN CO., LTD. 国食药监械(进)字2006第3400929 189.D-二聚体排除试验试剂盒 (bioMerieux,sa 国食药监械(进)字2005第3401130号(更))190.多功能医疗护理床系列 (捷克共和国Linet spol.sr.o. 国食药监械(进)字2004第2542365号(更)) 191.Multifiltrate Cassette 管路系统 (德国 Fresenius Medical Care AG & Co.KGaA 国食药监械(进192.透析液过滤器 (Fresenius Medical Care AG & Co.KGaA 国食药监械(进)字2005第3453077号(更)) 193.穿刺针 (Fresenius Medical Care AG & Co.KGaA 国食药监械(进)字2004第3150589号(更))194.游离三碘甲状腺原氨酸试剂盒 (Siemens Medical Solutions Diagnostics 国食药监械(进)字2004 195.游离甲状腺素试剂盒 (Siemens Medical Solutions Diagnostics 国食药监械(进)字2004第340060 196.超声诊断系统 (意大利 ESAOTE SpAESAOTE SpA 国食药监械(进)字2007第3230621号)197.MicroPlex 弹簧圈系统 (MicroVention,Inc 国食药监械(进)字2005第3770791号(更))198.运动负荷试验诊断系统 (Philips Medical Systems 国食药监械(进)字2005第2212430号(更)) 199.动态心电图系统 (Philips Medical Systems 国药管械(进)字2003第2210893号(更))200.心电图机 ( 国食药监械(进)字2004第2210828号(更))201.监护除颤器 (Philips Medical System 国食药监械(进)字2004第3211207号(更))202.正电子发射断层成像系统 (Philips Medical Systems (Cleveland),Inc. 国食药监械(进)字2003第203.免疫球蛋白G诊断试剂盒 (Siemens Medical Solutions Diagnostics 国食药监械(进)字2005第340204.Rapidpoint Coag 快速凝血仪PT-NC测试卡 (Siemens Medical Solutions Diagnostics 国食药监械205.髋关节假体(商品名：SDC and PLC) (德国 AESCULAP AG & Co.KGGermany AESCULAP AG & Co.KG 国206.膝关节系统(商品名：AGC DA) (英国 Biomet UK LTD.Biomet UK LTD. 国食药监械(进)字2007第34 207.疝修补网织片(商品名：巴德 Modified Kugel) ( 国食药监械(进)字2007第3460593号)208.角膜接触镜(商品名：强生彩镜) (美国 VISTAKON Johnson&Johnson Vision Care Inc. 国食药监械209.角膜接触镜(商品名：西武) (G&G CONTACT LENS CO. 国食药监械(进)字2007第3220572号)210.超声诊断仪 (GE Medical Systems Kretztechnik GmbH&Co.,OHG 国食药监械(进)字2007第3230494 211.超声诊断系统(商品名：SONOLINE G60 S) (美国 SIEMENS MEDICAL SOLUTIONS USA, INC. 国食药监212.Rapidpoint Coag 快速凝血aPTT测试卡 (Siemens Medical Solutions Diagnostics 国食药监械(进213.银粉玻璃离子水门汀(商品名：而至 Miracle Mix) (日本株式会社而至国食药监械(进)字2007第3 214.氟化泡沫(商品名：氟化泡沫) (美国 Laclede, A Laclede, Inc. 国食药监械(进)字2007第215.去白细胞滤器 (Fresenius Kabi AG 国食药监械(进)字2006第3660078号(更))216.硬膜下电极 (AD-Tech Medical Instrument Corporation 国食药监械(进)字2005第3210648号(更) 217.一次性使用去白细胞滤器 ( 国食药监械（进）字2007第3451019号)218.股骨头及内称(商品名：股骨头及内称) (法国 GROUPE LEPINE 国食药监械（进）字2007第3460914 219.补体C4诊断试剂盒 (Siemens Medical Solutions Diagnostics 国食药监械(进)字2005第3401774号220.生化校准液 ( 国食药监械(进)字2006第3400191号(更))221.口腔科手术器械 (德国 Alfred Becht GmbHGermany Alfred Becht GmbH 国食药监械(进)字2007第222.泌尿肛肠外科手术器械 (德国 Aesculap AG & Co.KG 国食药监械(进)字2007第1090477号)223.游离四碘甲状腺原氨酸试剂盒 (Siemens Medical Solutions Diagnostics 国食药监械(进)字2004 224.维生素B12稀释液 ( 国食药监械(进)字2005第3401705号(更))225.B型心钠素校准液 ( 国食药监械(进)字2005第3401785号(更))226.体外循环用插管--心室插管 (Maquet Cardioplumonary AG 国食药监械(进)字2004第3450692号(更227.体外循环用插管--静脉插管 (Maquet Cardioplumonary AG 国食药监械(进)字2004第3450694号(更228.脊椎动力平衡治疗系统 (Optima Health Solutions International Corporation 国食药监械(进) 229.手术室包 (Buckley Lamb Limited 国食药监械(进)字2005第2641933号(更))230.超声成像诊断仪 (Esaote Europe B.V. 国食药监械(进)字2006第3210425号(更))231.免疫球蛋白M诊断试剂盒 ( 国食药监械(进)字2005第3401709号(更))232.妥布霉素试剂盒 ( 国食药监械(进)字2005第3401695号(更))233.苯巴比妥试剂盒 ( 国食药监械(进)字2005第3401693号(更))234.氨测定试剂盒 (日本关东化学株式会社国食药监械(进)字2007第3400674号)235.肌红蛋白测定试剂盒 (日本关东化学株式会社国食药监械(进)字2007第3400675号)236.胃蛋白酶原Ⅰ测定试剂盒 (关东化学株式会社国食药监械(进)字2007第3400676号)237.全瓷(商品名：维他全瓷系列) (德国维他公司 VITA Zahnfabrik H.Rauter Gmbh & Co.KG 国食药238.齿科用铸造合金 (商品名：Solaro 3 ) (瑞士 Metalor Technologies SAMetalor Technologies S 239.齿科烤瓷合金(商品名：V-Gnathos plus ) ( 国食药监械(进)字2007第2630623号)240.齿科烤瓷合金(商品名：V-Deltaloy) (Metalor Technologies SA 国食药监械(进)字2007第263062 241.可吸收外科缝线(商品名：万福（Monosyn）) (德国 AESCULAP AG & CO.KG 国食药监械(进)字2007 242.静脉插管 (美国 Edwards Lifesciences LLC 国食药监械(进)字2007第3660520号)243.肾造瘘扩张器及套装(商品名：Amplatz) (Cook Urological Incorporated 国食药监械(进)字2007 244.连通板英文名称： Merit Manifolds(商品名：麦瑞连通板) (美国麦瑞医疗设备有限公司麦瑞医疗245.铁蛋白试剂盒 (Siemens Medical Solutions Diagnostics 国食药监械(进)字2004第3400273号(更246.高密度脂蛋白测定试剂盒 (日本关东化学株式会社国食药监械(进)字2007第3400673号)247.图像处理装置 (日本オリンパスメディカルシステムズ株式会社国食药监械(进)字2007第222044 248.内窥镜摄像系统 (Karl Storz GmbH & Co.KG 国食药监械(进)字2007第2220473号)249.接触式压电眼压计(商品名：动态轮廓眼压计) (SMT Swiss Microtechnology AG 国食药监械(进)字250.内窥镜下无源手术器械(商品名：蛇牌) (Aesculap AG&Co.KG 国食药监械(进)字2007第2220528号) 251.内窥镜摄像系统 (德国 Karl Storz GmbH & Co.KG 国食药监械(进)字2007第2220554号)252.医学影像存储和传输系统(商品名：医学影像存储和传输系统) (德国 Siemens AGSiemens AG 国食253.内窥镜冷光源 (德国 Richard Wolf GmbH 国食药监械(进)字2007第2220633号)254.牛心包生物瓣(商品名：SJM Biocor) (圣犹达医疗用品公司国食药监械(进)字2007第3460701号) 255.呼吸机(商品名：纽邦呼吸机) (美国 Newport Medical Instruments,Inc.U.S.A.Newport Medical 256.ADVIA 70 血液分析仪 (Siemens Medical Solutions Diagnostics 国药管械(进)2003第2400740号257.ADVIA 血液分析仪 (Siemens Medical Solutions Diagnostics 国药管械(进)2003第2400657号(更258.Kodak Min-R EV乳房X线影像胶片 (Carestream Health,Inc 国食药监械(进)字2004第1310201号(更259.Kodak DVM胶片 ( 国食药监械(进)字2005第1311759号(更))260.超声诊断设备(商品名：超声诊断设备Aplio) (日本 TOSHIBA MEDICAL SYSTEMS CORPORATION 国食261.层析柱 (TOSOH CORPORATION 国食药监械(进)字2007第3460551号)262.自动体外除颤仪 (Medtronic Emergency Response Systems,Inc. 国药管械(进)2002第3211124号( 263.电动动力系统 ( 国食药监械(进)字2005第2211873号(更))264.显微外科手术器械 (德国 Aesculap AG & Co.KGAesculap AG & Co.KG 国食药监械(进)字2007第10 265.根管扩大器 (日本　Mani, Inc. 国食药监械(进)字2007第2550455号)266.喷粉洁牙手机(商品名：PROPHY-MATE) (日本株式会社中西/Nakanishi Inc. 国食药监械(进)字20 267.脉动预真空压力蒸汽灭菌器 (Tuttnauer Co.Ltd. 国食药监械(进)字2007第2570703号)268.牙科复合树脂充填材料(商品名：SwissTec Composite) (Coltene/Whaledent AG 国食药监械(进)字269.ADVIA 70 鞘液 ( 国食药监械(进)字2003第3400427号(更))270.ADVIA 70 稀释液 ( 国食药监械(进)字2003第3400428号(更))271.ADVIA 70 溶血剂 ( 国食药监械(进)字2003第3400429号(更))272.ADVIA 60 TIMEPAC ( 国食药监械(进)字2005第2400926号(更))273.ADVIA 60 血液分析仪 ( 国食药监械(进)字2005第2401875号(更))274.万古霉素校准液 ( 国食药监械(进)字2005第3401795号(更))275.庆大霉素校准液 (Siemens Medical Solutions Diagnostics 国食药监械(进)字2005第3401794号( 276.远程心电事件记录器 (德国 TMS Telemedizinische Systeme GmbH 国食药监械(进)字2007第22105 277.生物显微镜 (德国 Carl Zeiss AG，Werk Gottingen 国食药监械(进)字2007第2220441号)278.深部电极 (Ad-Tech Medical Instrument Corporation 国食药监械(进)字2005第3210459号(更)) 279.硬膜外麻醉导管 (美国 ARROW INTERNATIONAL INC 国食药监械(进)字2007第3660588号)280.膜型血浆分离器 (日本旭化成医疗株式会社国食药监械(进)字2007第3660590号)281.血栓抽吸导管(商品名：Rebirth ) (日本株式会社Goodman 国食药监械(进)字2007第3660607号) 282.一次性使用输液器用输液帽、防回流阀 (德国 Fresenius Kabi AGFresenius Kabi AG 国食药监械283.Rapidpoint Coag 快速凝血仪 (Siemens Medical Solutions Diagnostics 国食药监械(进)字2003284.胃蛋白酶原Ⅱ测定试剂盒 (日本关东化学株式会社国食药监械(进)字2007第3400677号)285.血脂正常值质控 (德国罗氏诊断有限公司国食药监械(进)字2007第3400678号)286.血脂病理值质控 (德国罗氏诊断有限公司国食药监械(进)字2007第3400679号)287.免疫球蛋白G2试剂 (德国 Dade Behring Marburg GmbH 国食药监械(进)字2007第3400680号)288.免疫球蛋白G1试剂 (德国 Dade Behring Marburg GmbH 国食药监械(进)字2007第3400681号)289.铁蛋白检测试剂盒 (西班牙博士泰公司国食药监械(进)字2007第3400682号)290.脑脊液/尿液总蛋白检测试剂盒 (西班牙博士泰公司国食药监械(进)字2007第3400683号)291.HydroCoil栓塞系统 (MicroVention,Inc 国食药监械(进)字2005第3770789号(更))292.泵用输液器英文名称：Original Infusomat Tubing(商品名：Original Infusomat) (B. Brau 293.麻醉系统(商品名：Zeus) ( 国食药监械(进)字2007第3540615号)294.呼吸加湿过滤系统 (马来西亚 Rusch Sdn Bhd. 国食药监械(进)字2007第3540736号)295.光固化玻璃离子水门汀(商品名：而至富士 II LC ) (日本株式会社而至国食药监械(进)字2007第296.C-肽试剂盒 (Siemens Medical Solutions Diagnostics 国食药监械(进)字2004第3400619号(更)) 297.胰岛素试剂盒 (Siemens Medical Solutions Diagnostics 国食药监械(进)字2004第3400287号(更298.胰岛素试剂盒 (Siemens Medical Solutions Diagnostics 国食药监械(进)字2004第3400637号(更299.校准液O ( 国食药监械(进)字2005第3401792号(更))300.茶碱试剂盒 ( 国食药监械(进)字2005第3401694号(更))301.动力系统(商品名：Colibri ) (瑞士 Synthes GmbH 国食药监械(进)字2007第2540714号)302.免疫球蛋白A诊断试剂盒 ( 国食药监械(进)字2005第3401710号(更))303.KODAK DirectView CR950 系统 (Carestream Health,Inc 国食药监械(进)字2003第2310504号(更) 304.通用稀释液3 ( 国食药监械(进)字2005第3401699号(更))305.校准液Z ( 国食药监械(进)字2005第3401786号(更))306.校准液E ( 国食药监械(进)字2005第3401799号(更))307.肌酸激酶MB同工酶液体试剂盒 (DiaSys Diagnostic Systems GmbH 国食药监械(进)字2005第24031 308.自体血连续回输机 (Fresenius Kabi AG 国食药监械(进)字2005第3452722号(更))309.S5L/C5L 血小板套件 (Fresenius Kabi AG 国食药监械(进)字2006第3450453号(更))310.PL1血浆置换组件 (Fresenius Kabi AG 国食药监械(进)字2006第3450452号(更))311.血细胞分离机 (Fresenius Kabi AG 国食药监械(进)字2005第3453128号(更))312.CATS自体血回输机耗材 (Fresenius Kabi AG 国食药监械(进)字2006第3450451号(更))313.去白细胞滤器 (Fresenius Kabi AG 国食药监械(进)字2005第3453185号(更))314.通用稀释液4 ( 国食药监械(进)字2005第3401700号(更))315.C反应蛋白诊断试剂盒 (Siemens Medical Solutions Diagnostics 国食药监械(进)字2005第34017316.腹腔镜用缝合材料及辅助器械 (Ethicon Endo-Surgery, Inc. 国食药监械(进)字20317.一次性使用冲洗装置(商品名：CritiFlo) (新加坡　Becton Dickinson Critical Care Systems P 318.一次性使用电刀笔 (TELEFLEX MEDICAL 国食药监械(进)字2005第2252933号(更))319.导电性粘合电极板 (TELEFLEX MEDICAL 国食药监械(进)字2005第2252946号(更))320.R-Stent Evolution 2 冠状动脉支架系统 (美国 Orbus Neich Medical,Inc. 国食药监械(进)字20 321.程控仪(商品名：ZOOMLATITUDE) (美国　Guidant Corporation Cardiac Pacemakers Inc. 国食药322.植入式心脏除颤电极导管 ( 国食药监械(进)字2006第3211955号(更))323.二氧化碳(CO2)液体试剂盒 ( 国食药监械(进)字2004第3400627号(更))324.铁蛋白测定试剂 ( 国食药监械(进)字2004第3400628号(更))325.超声治疗仪(商品名：骨科超声治疗仪) (赛特力公司国食药监械(进)字2007第2230109号)326.中频电疗仪(商品名：Superkine SK-SERIES) ( 国食药监械(进)字2007第2260157号)327.影像板扫描处理系统(商品名：柯达 CR 7400 牙科计算机放射成像系统) (美国　Eastman Kodak C 328.凝血酶原时间测定试剂盒 ( 国食药监械(进)字2007第2400118号)329.凝血酶原时间测定试剂盒 ( 国食药监械(进)字2007第2400119号)330.谷氨酰转肽酶测定试剂盒 (和光纯药工业株式会社国食药监械(进)字2007第2400121号)331.PTA 导管（Amphirion DEEP） (意大利 Invatec S.r.l. 国食药监械(进)字2006第2771389号)。

依来曲普坦

依来曲普坦 Eletriptan【通用名】：依来曲普坦【中文化学名】：5-［2-（苯磺酰基）乙基］-3-［1-甲基吡咯烷-2(R)-基甲基］-1H-吲哚【英文化学名】：5-［2-（benzenesulfonyl ）ethyl ］-3-［1-methylpyrrolidin-2(R)-ylmethy ］-1H-indole【商品名】：Repax 【异名（别名）】：马来酸阿莫曲普坦、阿莫曲普坦、阿莫曲坦、依立曲坦、依西曲坦【缩写】：依立曲坦、依西曲坦【华学文摘号】：CA 117: 171215n 【CAS 登陆号】：［143322-58-1］【分子式】：C 22H 26N 2O 2S 【分子量】：382.53 【结构式】：HNNS O O【专利号】：WO 9206973, US 5545644, US 5607951 【专利到期年份】：【原研机构】：美国Pfizer 公司【首次上市时间】：2001年5月【首次上市国家】：澳大利亚、丹麦、挪威、瑞典、瑞士【物理与化学性质】：白色或淡灰白色粉末，易溶于水，水溶度为1.18*10^-3mg/mL 【主要作用与功效】：治疗偏头痛【常用剂型】：薄膜包衣片：每片20mg 或40mg 。

【注意事项】：对本品任何成分过敏者禁用本品；严重肝肾受损者、高血压未控制者、冠心病、周围血管病、有脑血管意外（CV A ）或暂时性局部缺血发作（TIA ）史的患者禁用。

轻中度肾脏受损者及怀孕、哺乳期妇女、儿童需慎用。

本品不可与麦角胺、麦角胺衍生物（包括美西麦角）或其他5-HT 1受体激动剂同时使用。

本品可增加CYP3A4抑制剂的血药浓度，包括红霉素、维拉帕米、酮康唑、依曲康唑、萘法唑酮、醋竹桃霉素、克拉霉素、利托那韦及那非那韦，因而至少72小时内不可与之合用。

【合成路线】：路线一：N BrHNLiAlH THF,refluxPd(OAc)2,(o-tol yl)3P Et 3N,DMF,refluxSOOSOSO路线二：NBrHNLiAlH THF,refluxPd(OAc)2,(o-tolyl)3P Et 3N,DMF,refluxSOSOw is acid,CH Cl 2Ao 2O,El 3N,DMF SOK 2CO 3,MeOH路线三：NH.HClOH KOH,CbzCl,HO,tolueneNNCbzOMeOOBrMg THF,O ON OCbzO ONMeHO 2CCO 2HDlbenzoyl-L-tartarlc acldO2HeletrlptanPhO 2SN N OO H H(【参考文献】：［1］李晓东. 偏头痛治疗药依来曲普坦（eletriptan ）.世界临床药物，2003,24（2）：122-123.［2］刘萍，边强. Replax 中国新药杂志，2004,13（1）：79-80.［3］郑红云.治疗偏头痛的新药Eletriptan 。

Keap1

非小细胞肺癌(non-small cell lung cancer，NSCLC)发病率占据肺癌的75%~80%。

肿瘤细胞进展快且易扩散转移，临床常采用手术、放化疗等进行治疗，但5年生存率低于60%[1-2]。

氧化应激是由活性氧(ROS)生成量增加所致，ROS积累可诱导肺癌细胞凋亡，清除ROS 可阻止癌细胞凋亡，即肺癌细胞存活依赖于癌细胞自身抗氧化能力[3]。

Kelch样环氧氯丙烷相关蛋白-1 (kelch-like epichlorohydrin-associated protein-1，Keap1)/核因子E2相关因子2(nuclear factor E2related factor 2，Nrf2)信号通路在癌症中发挥重要调控作用，氧化应激可激活Keap1，促使Keap1-Nrf2复合物裂解，Nrf2转移至细胞核内，可激活下游靶基因表达，参与肺癌发生发展过程[4]。

Nrf2可维持氧化还原稳态，ROS侵袭细胞时，Nrf2可进入细胞核，结合抗氧化反应元件(ARE)转录编码各种抗氧化蛋白、代谢酶基因，抑制氧化应激反应[5-6]。

目前氧化应激、Keap1/Nrf2信号通路在NSCLC发生过程中的机制尚未明确。

基于此，本研究尝试分析Keap1/Nrf2信号通路与临床病理参数、氧化应激指标的相关性，探讨其在NSCLC氧化应激机制中的作用，为临床研制新药提供参考依据。

1资料与方法1.1一般资料选取2017年4月至2020年4月郑州市第三人民医院收治的100例NSCLC患者为研究对象。

纳入标准：符合NSCLC诊断标准[7]；术前未接受放化疗、免疫治疗者；预计生存期≥6个月；符合手术适应证、禁忌证；Karnofsky功能状态评分≥70分；签署知情同意书。

排除标准：合并凝血功能障碍、肝肾功能障碍、其他恶性肿瘤者；伴有急/慢性感染者；伴有精神疾病者；既往腹部相关外科手术史者。

所有患者均行肺癌根治性切除术，术中收集癌组织、癌旁组织(距离癌组织5cm范围内正常组织)，其中男性63例，女性37例；年龄46~67岁，平均(56.32±3.16)岁；体质量指数(BMI)17~30kg/m2，平均(23.16±2.03)kg/m2；病理类型：鳞癌58例、腺癌42例；病理分级[8]：Ⅰ~Ⅱ级51例、Ⅲ级49例；T分期[9]：T1~T253例、T3~T447例；N分期：N055例、N1~N245例。

乙酰胆碱酯酶抑制剂

上海应用技术学院研究生课程《高等天然产物化学》试卷2014 / 2015 学年第1 学期课程代码：NX0702013论文题目：乙酰胆碱酯酶抑制剂的研究进展姓名：芮银146061414康满满146061409专业：制药工程学院：化工学院乙酰胆碱酯酶抑制剂的研究进展芮银，陈祎桐，康满满摘要：本文阐述了乙酰胆碱酯酶抑制剂(AChEI)的研究进展，介绍了用于药物治疗的乙酰胆碱酯酶抑制剂的各种来源如植物、微生物等，及其抑制乙酰胆碱的活性物质。

在此基础上，总结了几种现代分析技术，对AChEIs进行筛选，大大加快AD药物资源的开发利用进程。

这些方法主要有基于比色法的Ellman's法及相关的改进方法、薄层显色法、荧光显色法、电喷雾质谱法等。

但是，到目前为止，现代分析技术在AD药物资源中的应用还处在起步阶段。

关键词：乙酰胆碱酯酶抑制剂，筛选方法，薄层显色法，荧光显色法The progress of acetylcholinesteraseinhibitorsRui Yin, Chen Yitong, Kang ManmanAbstract：In this artical, the research elaborates progress of acetylcholinesterase inhibitors (AChEI), and introduces a variety of sources for drug treatment acetylcholinesterase inhibitors such as plants, microorganisms, and its active ingredients. On this basis, the review summarizes several modern analytic techniques such as Ellman's method which based on the colorimetric method, TLC chromogenic method, fluorescent color method, Electrospray ionization mass spectrometry and so on. However, at present, the application of modern analytic techniques in AD drug resources is still in infancy.Key word: Acetylcholinesterase inhibitors, Screening Methods, TLC chromogenic method, Fluorescent color method目录摘要.................................................................................................错误!未定义书签。